Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-054230
Filing Date
2008-03-12
Accepted
2008-03-12 16:40:50
Documents
11
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1194975
2 THIRD PARTY MANUFACTORING AGREEMENT dex1044.htm EX-10.44 118320
3 LIST OF SUBSIDIARIES dex21.htm EX-21 871
4 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1673
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER REQUIRED BY RULE 13A-14(A) dex311.htm EX-31.1 6372
6 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER REQUIRED BY RULE 13A-14(A) dex312.htm EX-31.2 6452
7 CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER REQUIRED BY RULE 13A-14(A) dex313.htm EX-31.3 6416
8 SECTION 1350 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex321.htm EX-32.1 3854
9 SECTION 1350 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex322.htm EX-32.2 3878
10 SECTION 1350 CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER dex323.htm EX-32.3 3794
11 GRAPHIC g33679g06l89.jpg GRAPHIC 52999
  Complete submission text file 0001193125-08-054230.txt   1421088
Mailing Address
Business Address 600 COLLEGE ROAD EAST SUITE 3200 PRINCETON NJ 08540 6099451200
BARRIER THERAPEUTICS INC (Filer) CIK: 0001173657 (see all company filings)

EIN.: 223828030 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50680 | Film No.: 08683952
SIC: 2834 Pharmaceutical Preparations